Joseph M. Burnett - 02 Sep 2026 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Reporting relationship: CEO and President, Director
Issuer ticker: CLPT
Reported as of: 02 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Sep 2026, 18:22:12 UTC
Prior SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett

Key filing fact

Joseph M. Burnett filed Form 4 for ClearPoint Neuro, Inc. (CLPT) on 03 Sep 2026.

Key facts

This page summarizes Joseph M. Burnett's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Sep 2026, 18:22.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001721010 Primary reporting owner

BURNETT JOSEPH

Relationship: CEO and President, Director
Address: C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH
Signature: /s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett
Signature date: 02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLPT transaction

Common Stock

Options Exercise

Transaction value
Shares: +12,517
Change %: +11%
Price: $3.47^*
Shares after: 130,720
Date: 02 Sep 2026
Ownership: Direct
Footnotes: F1

CLPT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 191,388
Date: 02 Sep 2026
Ownership: See footnote
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLPT transaction Derivative

Stock Options (right to buy)

Options Exercise

Transaction value
Shares: -12,517
Change %: -17%
Price: $0.000000^*
Shares after: 61,887
Date: 02 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,517
Exercise price: $3.47
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Mr. Burnett paid the exercise price for the options in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction.

Footnote F2

These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.

Footnote F3

The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. The grant date is August 15, 2019.